4//SEC Filing
ANI PHARMACEUTICALS INC 4
Accession 0001144204-14-015906
$ANIPCIK 0001023024operating
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:23 PM ET
Size
5.7 KB
Accession
0001144204-14-015906
Insider Transaction Report
Form 4
RAYNOR DANIEL
Director
Transactions
- Sale
Common Stock
2014-03-12$33.89/sh−21,111$715,452→ 3,324,738 total(indirect: See Footnote)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.21 to $34.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold by her at each separate price on each date of sale.
- [F2]These shares are held by Argentum Capital Partners II, L.P. (ACP II). Argentum Investments, LLC is the managing member of Argentum Partners II, LLC, which is the general partner of ACP II. Daniel Raynor is a co-managing member of Argentum Investments, LLC. Mr. Raynor disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The business address of ACP II is 60 Madison Avenue, Suite 701, New York, NY 10010.
Documents
Issuer
ANI PHARMACEUTICALS INC
CIK 0001023024
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001023024
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:23 PM ET
- Size
- 5.7 KB